Conflicts of interest in randomized controlled trials reported in neurosurgical journals

Abstract

OBJECTIVERandomized controlled trials (RCTs) form the basis of today’s evidence-based approach to medicine, and play a critical role in guidelines and the drug and device approval process. Conflicts of interest (COIs) are commonplace in medical research, but little is known about their influence. The authors aimed to evaluate the extent and influence of COIs in recent RCTs published in core neurosurgical journals using a cross-sectional analysis.METHODSThrough review of 6 general neurosurgical journals, all interventional RCTs published from January 2009 to January 2019 were identified. Because it is difficult to objectively assess study outcome, the authors opted for a strict rating approach based on the statistical significance of unambiguously reported primary endpoints, and the reported statistical protocol.RESULTSA total of 129 RCTs met the inclusion criteria. During the study period, the Journal of Neurosurgery published the largest number of RCTs (n = 40, 31%). Any potential COI was disclosed by 57%, and a mean of 12% of authors had a personal COI. Nonfinancial industry involvement was reported in 10%, while 31% and 20% received external support and sponsoring, respectively. Study registration was reported by 56%, while 51% of studies were blinded. Registration showed an increasing trend from 17% to 76% (p < 0.001). The median randomized sample size was 92 (interquartile range 50–153), and 8% were designed to investigate noninferiority or equality. Sixty-three RCTs (49%) unambiguously reported a primary endpoint, of which 13% were composite primary endpoints. In 43%, study outcome was positive, which was associated with a noninferiority design (31% vs 3%, p = 0.007) and a composite primary endpoint (46% vs 9%, p = 0.002). Potential COIs were not significantly associated with study positivity (69% vs 59%, p = 0.433). In the multivariate analysis, only a composite primary endpoint remained predictive of a positive study outcome (odds ratio 6.34, 95% confidence interval 1.51–33.61, p = 0.017).CONCLUSIONSThis analysis provides an overview of COIs and their potential influence on recent trials published in core neurosurgical journals. Reporting of primary endpoints, study registration, and uniform disclosure of COIs are crucial to ensure the quality of future neurosurgical randomized trials. COIs do not appear to significantly influence the outcome of randomized neurosurgical trials.

Clinical Benefit of Vagus Nerve Stimulation for Epilepsy: Assessment of Randomized Controlled Trials and Prospective Non-Randomized Studies

“… 35 That said, such findings have not been recapitulated for neurosurgical RCTs specifically. 36 Confirmation of the efficacy of VNS in the 2 non-industry sponsored studies provides further reassurance.…”

The European Robotic Spinal Instrumentation (EUROSPIN) study: protocol for a multicentre prospective observational study of pedicle screw revision surgery after robot-guided, navigated and freehand thoracolumbar spinal fusion

“…A specific goal of the EUROSPIN trial is to avoid potential conflicts of interest 55. Therefore, we decline any sort of direct involvement and study-related financial support by the industry, and aim to minimise personal conflict of interests with device manufacturers.…”

“…Therefore, we decline any sort of direct involvement and study-related financial support by the industry, and aim to minimise personal conflict of interests with device manufacturers. This may enable execution and critical appraisal of the study results with less bias 55 56…”

Clinical trial implementation: a primer for neurosurgeons

“…FCOI are an especially pertinent issue with industry-sponsored trials, with both sponsors and research staff sharing the responsibility of ensuring transparent and unbiased study results. 30,31 At this point, all relevant staff should be prepared to evaluate the study protocol at the feasibility meeting.…”